A detailed history of Nomura Asset Management CO LTD transactions in Arvinas, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 90,870 shares of ARVN stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
90,870
Previous 66,647 36.35%
Holding current value
$1.64 Million
Previous $1.77 Million 26.16%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$23.66 - $32.73 $573,116 - $792,818
24,223 Added 36.35%
90,870 $2.24 Million
Q2 2024

Aug 14, 2024

BUY
$24.46 - $40.4 $141,232 - $233,269
5,774 Added 9.49%
66,647 $1.77 Million
Q4 2023

Feb 09, 2024

BUY
$14.19 - $42.33 $863,787 - $2.58 Million
60,873 New
60,873 $2.51 Million
Q3 2023

Nov 03, 2023

BUY
$19.64 - $28.21 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023

BUY
$21.73 - $31.43 $0 - $0
0 New
0 $0
Q1 2023

Jan 10, 2025

BUY
$26.15 - $37.26 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023

BUY
$26.15 - $37.26 $0 - $0
0 New
0 $0
Q4 2022

Jan 10, 2025

BUY
$32.47 - $57.24 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023

BUY
$32.47 - $57.24 $0 - $0
0 New
0 $0
Q3 2022

Jan 10, 2025

BUY
$41.87 - $57.99 $0 - $0
0 New
0 $0
Q3 2022

Nov 14, 2022

BUY
$41.87 - $57.99 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022

BUY
$41.87 - $57.99 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022

BUY
$41.87 - $57.99 $0 - $0
0 New
0 $0
Q2 2022

Jan 10, 2025

SELL
$36.01 - $74.24 $167,014 - $344,325
-4,638 Closed
0 $0
Q2 2022

Aug 12, 2022

SELL
$36.01 - $74.24 $167,014 - $344,325
-4,638 Closed
0 $0
Q1 2022

Jan 10, 2025

SELL
$60.27 - $81.57 $5.2 Million - $7.03 Million
-86,232 Reduced 94.9%
4,638 $312,000
Q4 2021

Jan 10, 2025

BUY
$65.85 - $96.21 $305,412 - $446,221
4,638 New
4,638 $380,000
Q4 2021

Feb 01, 2022

BUY
$65.85 - $96.21 $305,412 - $446,221
4,638 New
4,638 $381,000
Q3 2021

Jan 10, 2025

BUY
$73.2 - $107.87 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021

BUY
$73.2 - $107.87 $0 - $0
0 New
0 $0
Q2 2021

Jan 10, 2025

BUY
$60.45 - $84.26 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021

BUY
$60.45 - $84.26 $0 - $0
0 New
0 $0
Q1 2021

Jan 10, 2025

SELL
$58.19 - $91.37 $5.29 Million - $8.3 Million
-90,870 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$58.19 - $91.37 $0 - $0
0 New
0 $0
Q4 2020

Jan 10, 2025

SELL
$20.19 - $84.93 $1.83 Million - $7.72 Million
-90,870 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$20.19 - $84.93 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020

BUY
$22.99 - $36.34 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$29.88 - $56.74 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020

BUY
$33.0 - $54.5 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020

BUY
$15.39 - $44.38 $0 - $0
0 New
0 $0

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $960M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.